Expand PDSB Menu
PDSB MENU

PDSB Stock Posts


Unusual Option Volume

PDSB PDS Biotechnology0.93-0.03 (-3.1%)

PDS Biotechnology trades 2,680 contracts.
Unusual Option Volume

PDSB PDS Biotechnology1.03-0.02 (-1.9%)

PDS Biotechnology trades 2,510 contracts. The highest volume is in the 20-Nov-26 2.5 calls, which is 142.7% above the current price.
Unusual Option Volume

PDSB PDS Biotechnology1.31+0.25 (+23.6%)

PDS Biotechnology trades 3,568 contracts. The highest volume is in the 20-Nov-26 2.5 calls, which is 90.8% above the current price. News: PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
Unusual Option Volume

PDSB PDS Biotechnology1.12+0.19 (+20.0%)

PDS Biotechnology trades 2,245 contracts. The company has the following event: Meeting with FDA to Explore Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer on Oct 29, 2025. News: PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
$PDSB Earnings August 13 BMO. Expected Move ±7.5% vs Prev. Move +3.1%
Unusual Option Volume

PDSB PDS Biotechnology3.73-0.75 (-16.7%)

Market Data Delayed 15 Minutes